Biocon
Satyanarayana Turlapati has a diverse and extensive work experience spanning over multiple companies and roles. Starting in 1996, they worked as an Accountant at SIRIS Vijayawada until 1999. Satyanarayana then joined Aurobindo Pharma Limited in 2000 as an Assistant Manager. In 2006, they moved on to Mylan Laboratories Limited, where they served as a General Manager until 2022. From there, they joined Viatris as a General Manager and later became a Senior General Manager, working until July 2023. Currently, they hold the position of Head of Operations Finance at Biocon, starting in July 2023.
Satyanarayana Turlapati completed their intermediate education at V R High School in Nellore from 1987 to 1988. Following that, they pursued Bachelor of Commerce (B.Com.) with a specialization in ACMA at PB Siddartha College of Arts & Science in Vijayawada from 1990 to 1993.
This person is not in any teams
This person is not in any offices
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.